Scienture Holdings, Inc.获得PBM主导的GPO返利协议,推动Arbli™(氯沙坦钾)在2.56亿美元美国氯沙坦市场中扩大商业保险覆盖和药物名录准入

美股速递
Sep 16, 2025

Scienture Holdings, Inc.成功获得PBM主导的GPO返利协议,旨在推动其药物Arbli™(氯沙坦钾)在价值2.56亿美元的美国氯沙坦市场中扩大商业保险覆盖范围和药物名录准入机会。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10